People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related ...

The nasal spray zavegepant, sold as Zavzpret ... Zavzpret is the first to work by blocking the calcitonin gene-related peptide, CGRP, a protein that is released in the brain that contributes ...

Credit: Pfizer. Zavzpret (zavegepant) nasal spray is a calcitonin gene-related peptide (CGRP) receptor antagonist. The Food and Drug Administration (FDA) has approved Zavzpret ™ (zavegepant ...

Zavegepant (brand name: Zavzpret), is the first of a class of migraine treatments known as calcitonin gene-related peptide receptor (CGRP) antagonists to be approved as a nasal spray. Until now ...

By Christina Jewett The Food and Drug Administration has approved a Pfizer nasal spray for treatment of ... to block the release of proteins called calcitonin gene-related peptides, which studies ...

People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related ...